sufentanil has been researched along with Cancer Pain in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Du, B; Guo, Q; Qi, X; Wang, B; Xiao, F; Zhang, H; Zhang, J | 1 |
| Feng, Z; Guo, J; Guo, X; Peng, Z; Zhang, Y | 1 |
2 other study(ies) available for sufentanil and Cancer Pain
| Article | Year |
|---|---|
Clinical efficacy of sufentanil combined with dexmedetomidine in patient-controlled subcutaneous analgesia for advanced cancer pain.
Topics: Analgesia, Patient-Controlled; Cancer Pain; Dexmedetomidine; Humans; Neoplasms; Pain; Sufentanil; Treatment Outcome | 2023 |
Patient-Controlled Intravenous Analgesia for Advanced Cancer Patients with Pain: A Retrospective Series Study.
Topics: Aged; Analgesia, Patient-Controlled; Analgesics, Opioid; Cancer Pain; Female; Humans; Hydromorphone; Male; Middle Aged; Oxycodone; Pain Management; Patient Satisfaction; Retrospective Studies; Sufentanil | 2018 |